GlaxoSmithKline PLC (NYSE:GSK)
| 37.72 Delayed Data As of Apr 02 |  +0.02 / +0.05%Today’s Change | 31.43 Today|||52-Week Range 48.25 | -19.73% Year-to-Date |
Latest GSK News | Press Releases
| Is GlaxoSmithKline Stock a Buy? Apr 01 / MotleyFool.com - Paid Partner Content | 3 Stocks to Buy Ahead of the Next Market Crash Mar 28 / MotleyFool.com - Paid Partner Content |
| Eli Lilly Licenses Immunology Drugs for Up to $880 Million Mar 31 / MotleyFool.com - Paid Partner Content | 2 Dividend Stocks Trading at Dirt-Cheap Prices Mar 27 / MotleyFool.com - Paid Partner Content |
| Shares of Amarin Down 68% After Losing a Patent Lawsuit for Vascepa Mar 30 / MotleyFool.com - Paid Partner Content | Why Sanofi's Coronavirus Vaccine Work Hasn't Helped Its Stock Mar 21 / MotleyFool.com - Paid Partner Content |
| 3 Top Stocks to Buy With Your $1,200 Stimulus Check Mar 28 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 37.70 |
| Today’s open | 37.00 |
| Day’s range | 36.68 - 37.80 |
| Volume | 4,839 |
| Average volume (3 months) | 4,263,205 |
| Market cap | $91.5B |
Data as of 3:59pm ET, 04/02/2020
Growth & Valuation
| Earnings growth (last year) | +21.84% |
| Earnings growth (this year) | -9.08% |
| Earnings growth (next 5 years) | +2.81% |
| Revenue growth (last year) | +4.78% |
| P/E ratio | 16.4 |
| Price/Sales | 2.74 |
| Price/Book | 5.69 |
Competitors
Data as of 4:00pm ET, 04/02/2020
Financials
| Next reporting date | April 29, 2020 |
| EPS forecast (this quarter) | $0.74 |
| Annual revenue (last year) | $43.1B |
| Annual profit (last year) | $5.9B |
| Net profit margin | 13.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Middlesex, Greater London |
Forecasts
